Urgent

Graves thyrotoxicosis in pregnancy

Thyroid · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Hyperthyroidism in pregnancy, most often from Graves disease, risking maternal complications and fetal/neonatal thyrotoxicosis from transplacental TSH receptor antibodies. Requires careful antithyroid drug selection by trimester.

Figures & algorithms

Clinical features
Clinical features

Red flags

  • Features of thyroid storm
  • High TSH receptor antibody titres (fetal risk)
  • Fetal tachycardia, goitre or growth restriction
  • Uncontrolled maternal hyperthyroidism

Assessment

Differential diagnosis

  • Gestational transient thyrotoxicosis (hCG-mediated)
  • Hyperemesis gravidarum-associated thyroid changes
  • Toxic nodular goitre
  • Subacute thyroiditis
  • Thyroid storm

Investigations

  • TSH, free T4 and free T3 (trimester-specific ranges)
  • TSH receptor antibodies (predict fetal/neonatal disease)
  • Fetal monitoring (heart rate, growth, goitre)
  • FBC and liver function (antithyroid drug baseline)
  • Assess for thyroid storm if severely unwell

Management

  • Confirm true hyperthyroidism and distinguish from self-limiting gestational thyrotoxicosis
  • Use the lowest effective antithyroid drug dose (propylthiouracil preferred in the first trimester; carbimazole thereafter)
  • Monitor thyroid function frequently and titrate to keep free T4 in the upper normal range
  • Beta-blockade for symptomatic control if needed
  • Monitor for fetal thyrotoxicosis via antibodies and fetal surveillance
  • Involve endocrinology and obstetrics; avoid radioiodine (contraindicated)

Drugs & doses

Propylthiouracil in the first trimester; switch to carbimazole in the second/third
Beta-blocker (e.g. propranolol) short-term for symptoms
Radioiodine is contraindicated in pregnancy
Lowest effective doses to avoid fetal hypothyroidism

Disposition

Joint endocrine-obstetric care; admit if storm or severe disease.

Complications & pitfalls

  • Thyroid storm
  • Miscarriage, pre-eclampsia, preterm birth and growth restriction
  • Fetal/neonatal thyrotoxicosis or hypothyroidism
  • Antithyroid drug hepatotoxicity/agranulocytosis

Exam pearls

  • Propylthiouracil in the first trimester then carbimazole later balances teratogenicity risks
  • TSH receptor antibodies cross the placenta - high titres warn of fetal/neonatal thyrotoxicosis

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.